Viewing Study NCT03873818


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2026-02-25 @ 8:48 PM
Study NCT ID: NCT03873818
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-27
First Post: 2019-02-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Low Dose Ipilimumab With Pembrolizumab in Treating Patients With Melanoma That Has Spread to the Brain
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module